Market
Who cares?
Define users, buyers, workflow, positioning, pricing, and adoption logic.
Advisory · IP-rich innovation
Scientific progress needs a commercial pathway.
HHP works with companies and institutions where the technology is credible but the business, capital, partnerships, or operating model still needs to catch up. The problem determines the team.
The problem is connected
One isolated problem rarely exists.
Strong IP can still stall when customer logic, financing milestones, governance, partnerships, and operating capability are treated as separate workstreams. HHP brings those decisions into one commercial framework.
Capital
What must the next dollar prove?
Sequence milestones, financing, governance, and diligence readiness.
Access
Which relationship changes the trajectory?
Prioritize customers, strategic partners, and aligned capital sources.
Organization
What must the company become next?
Clarify leadership, capabilities, governance, and operating design.
Engagement models
Structured around the constraint.
Our work is designed around defined commercial and organizational inflection points rather than generic consulting scopes.
01 · 90 days
Commercial Architecture
Who cares, who pays, and why will they adopt?
Customer and economic buyer
Clinical or operational workflow
Positioning and pricing
Payment and path to first revenue
02 · 90 days
Institutional Readiness
What does the next dollar need to prove?
Capital requirement
Milestone architecture
Governance and diligence readiness
Sometimes the right answer is: do not raise yet
03 · 90 days
Strategic Access
What relationship would change the trajectory?
Commercial partners
Customers
Strategic investors
Partnership pursuit and positioning
04 · 6+ months
Organizational Architecture
What does the company need to become next?
Leadership assessment
Capability gaps
Governance
Operating design for the next stage
05 · 6+ months
Strategic Partner
What creates the most enterprise value from here?
Commercial growth
Capital strategy
Strategic relationships
Senior-level execution support
Custom services
IP & Asset Strategy
Specialized mandates where a focused transaction, asset, or structure requires senior-level support.
Licensing
Recapitalizations
Strategic alternatives & M&A
HoldCo development & asset combinations
The problem determines the team
Activated expertise, not a static bench.
HHP assembles the people required for the specific commercial constraint, drawing from capital, commercialization, finance, clinical, operating, risk, and partnership experience.
Capital & M&A
Stephen Ippolito
Investment, transaction, capital strategy, and enterprise-value architecture.
Commercialization
Dhairya Pujara
Go-to-market, opportunity design, institutional commercialization, and founder execution.
Finance & Operations
Chris Ippolito
Financial visibility, portfolio operations, and execution discipline.
Scientific & Clinical
Wilbur A. Lam, MD, PhD
Physician-scientist perspective, diagnostics, translational research, and academic innovation.
Clinical Innovation
James J. Chao, MD, FACS
Clinical entrepreneurship, healthcare delivery, and venture building.
Market Execution
Stacy Chick
Life sciences commercialization, financing, partnerships, and operating scale.
Risk & Regulation
Mike Cremeans
FDA-regulated risk, insurance architecture, and transaction support.
Partnerships
Aditya Khurjekar
Healthcare, venture building, strategic partnerships, product, and go-to-market execution.
Scope
Healthcare depth. Broader IP relevance.
Our deepest operating and investment focus is healthcare and life sciences. Advisory work can extend to IP-rich technologies in other sectors when the same commercialization problem is present: technically credible innovation that still needs market, capital, partnership, and organizational architecture.
HHP advisory engagements are independent of HHP investment decisions and do not guarantee financing or investment.